Allurion Technologies (ALURD) EBITDA Margin Growth (3y) (2025 - 2026)

Allurion Technologies (ALURD) EBITDA Margin Growth (3y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (3y) (Qtr)
1 Abbott Laboratories 186.78 Bn 179.48 Bn 6.27 Bn -343.00
2 Stryker 131.95 Bn 129.07 Bn 3.81 Bn 17.00
3 Medtronic 111.27 Bn 102.05 Bn 6.41 Bn 78.00
4 Boston Scientific 68.58 Bn 67.13 Bn 3.61 Bn 487.00
5 Edwards Lifesciences 48.31 Bn 44.63 Bn 1.29 Bn -283.00
6 GE HealthCare Technologies 29.23 Bn 26.94 Bn 1.98 Bn -184.00
7 Dexcom 28.90 Bn 27.78 Bn 750.30 Mn 1,505.00
8 Smith & Nephew 28.19 Bn 27.62 Bn - -
9 Koninklijke Philips 24.33 Bn 21.29 Bn 2.01 Bn -763.00
10 Allurion Technologies 60.75 Mn 55.69 Mn 1.23 Mn -2,782.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -2,782.00
Dec 31, 2025 -12,028.00
Sep 30, 2025 -28,769.00
Jun 30, 2025 -17,932.00